Molecular Docking of Natural Compounds to NF-kappaB
Author Information
Author(s): Piccagli Laura, Fabbri Enrica, Borgatti Monica, Bezzerri Valentino, Mancini Irene, Nicolis Elena, Dechecchi Maria C, Lampronti Ilaria, Cabrini Giulio, Gambari Roberto
Primary Institution: University of Ferrara, Italy
Hypothesis
Can natural compounds from medicinal plants inhibit NF-kappaB/DNA interactions?
Conclusion
The study identifies a promising lead compound that inhibits NF-kappaB activity and modulates IL-8 gene expression.
Supporting Evidence
- The docking performance was predictive of biochemical activity.
- Compound 21 showed strong inhibition of IL-8 mRNA accumulation.
- Docking studies were validated by EMSA experiments.
- Natural compounds were derived from medicinal plant extracts.
Takeaway
Scientists looked at natural compounds from plants to see if they could stop a protein called NF-kappaB from working, which helps control inflammation.
Methodology
Docking studies were performed on 27 natural compounds from medicinal plants to assess their binding to NF-kappaB p50.
Limitations
The docking protocol may not be fully applicable to proteins without a ligand present.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website